Search results
Pfizer's COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading...
Benzinga· 14 hours agoThe state of Kansas has reportedly filed a lawsuit against pharmaceutical giant Pfizer, Inc. PFE, accusing the company of violating consumer protection laws related to its ...
Will Pfizer Stock Rebound To Its 2021 Highs Of $60?
Forbes· 1 day agoPfizer stock (NYSE: PFE) currently trades at $28 per share, 55% below its peak level of $61 seen in December 2021. PFE stock was trading at $52 in early June 2022, just before ...
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks via Yahoo Finance· 5 days agoPfizer's (PFE) phase III study, CIFFREO, fails to show improvement in motor function in ambulatory...
Is It Too Late to Buy Pfizer Stock?
The Motley Fool via AOL· 4 days agoAre Pfizer's (NYSE: PFE) best days behind it? If the stock's critics are to be believed, the answer is an emphatic "yes, obviously," with issues like its...
Pfizer's Duchenne gene therapy fails in late-stage study
Reuters via Yahoo News· 5 days agoThe therapy also did not show a significant difference compared to placebo in secondary goals of the...
Flagship taps startup to hunt for obesity drugs that might interest Pfizer
BioPharma Dive via Yahoo Finance· 6 days agoThe venture firm will work with ProFound Therapeutics to “rapidly surface” protein drug candidates...
Kansas Attorney General Kris Kobach sues Pfizer for COVID-19 vaccine
WIBW Topeka· 15 hours agoKansas Attorney General Kris Kobach on Monday morning announced he is suing Pfizer for what he said...
Kansas Attorney General sues Pfizer for misleading covid claims
KOAM· 15 hours ago(KANSAS) -- Kansas Attorney General Kris Kobach is suing Pfizer for misleading claims made related to the COVID vaccine.
US FDA approves Merck's pneumococcal vaccine for adults
Reuters· 10 hours ago, opens new tab said on Monday the U.S. Food and Drug Administration has approved its...
Childress Capital Advisors LLC Has $583,000 Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 4 days agoChildress Capital Advisors LLC boosted its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 2.2% during the 4th quarter, according to its most recent 13F filing with the Securities ...